Publication | Closed Access

Trivalent Human Papillomavirus (HPV) VLP vaccine covering HPV type 58 can elicit high level of humoral immunity but also induce immune interference among component types

VaccinationVaccine DevelopmentCervical CancerHuman Papillomavirus VaccinesVlp VaccineMedicineVaccine TargetImmunologyVirologyVaccine DesignPolyvalent VaccineImmune InterferenceViral ImmunityHpv Type 58